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Abstract Renal phosphate reabsorption across the brush
border membrane (BBM) in the proximal tubule is mediated
by at least three transporters, NaPi-IIa (SLC34A1), NaPi-IIc
(SLC34A3), and Pit-2 (SLC20A2). Parathyroid hormone
(PTH) is a potent phosphaturic factor exerting an acute and
chronic reduction in proximal tubule phosphate reabsorp-
tion. PTH acutely induces NaPi-IIa internalization from the
BBM and lysosomal degradation, but its effects on NaPi-IIc
and Pit-2 are unknown. In rats adapted to low phosphate diet,
acute (30 and 60 min) application of PTH decreased BBM
phosphate transport rates both in the absence and the
presence of phosphonoformic acid, an inhibitor of SLC34
but not SLC20 transporters. Immunohistochemistry showed
NaPi-IIa expression in the S1 to the S3 segment of
superficial and juxtamedullary nephrons; NaPi-IIc was only
detectable in S1 segments and Pit-2 in S1 and weakly in S2
segments of superficial and juxtamedullary nephrons. PTH
reduced NaPi-IIa staining in the BBM with increased
intracellular and lysosomal appearance. NaPi-IIa internali-
zation was most prominent in S1 segments of superficial
nephrons. We did not detect changes in NaPi-IIc and Pit-2
staining over this time period. Blockade of lysosomal protein
degradation with leupeptin revealed NaPi-IIa accumulation
in lysosomes, but no lysosomal staining for NaPi-IIc or Pit-2
could be detected. Immunoblotting of BBM confirmed the
reduction in NaPi-IIa abundance and the absence of any
effect on NaPi-IIc expression. Pit-2 protein abundance was
also significantly reduced by PTH. Thus, function and
expression of BBM phosphate cotransporters are differen-
tially regulated allowing for fine-tuning of renal phosphate
reabsorption.
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Introduction
Renal phosphate excretion is mostly determined by the rate
of reabsorption of filtered phosphate along the proximal
tubule. To date, at least three distinct sodium-dependent
phosphate transporters have been identified to be expressed
in the brush border membrane (BBM) of the proximal
tubule: NaPi-IIa (SLC34A1), NaPi-IIc, and more recently
Pit-2 [7, 37, 43]. However, these transporters have distinct
transport properties with respect to ion coupling, preferred
species of phosphate, voltage sensitivity, and pH depen-
dence [31, 32, 36, 45]. NaPi-IIa and Pit-2 mediate the
electrogenic transport of inorganic phosphate coupled to
three and two sodium ions, respectively, whereas NaPi-IIc
transports inorganic phosphate together with two sodium
ions in an electroneutral fashion [31, 32, 36, 45]. Moreover,
NaPi-IIa and NaPi-IIc prefer divalent inorganic phosphate
(HPO4
2−). In contrast, Pit transporters preferentially trans-
port monovalent phosphate (H2PO4
−) [31, 32, 36, 45].
A plethora of factors affects renal phosphate reabsorp-
tion, among them parathyroid hormone (PTH), dopamine,
dietary phosphate intake, glucocorticoids, acid–base status,
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growth factors, insulin, and FGF-23 [1, 3, 6, 7, 32, 33]. The
hormonal regulation of the NaPi-IIa cotransporter has been
studied in much detail demonstrating that hormones such as
PTH, dopamine, FGF-23, sFRP4, MEPE, glucocorticoids
cause a reduction of NaPi-IIa expression [7]. Much less is
known about the hormonal regulation of NaPi-IIc with only
few studies showing that PTH and FGF-23 cause lower
expression [24, 38]. In contrast, no hormonal regulators of
Pit-2 have been reported to date. Dietary phosphate intake
or potassium depletion is the only known regulatory factor
of Pit-2 [10, 43].
PTH is one of the most potent acute phosphaturic factors
inducing urinary phosphate excretion within 15 to 45 min
after application [15, 19]. We and others have shown that
PTH causes phosphate excretion at least in part by inducing
the internalization of the NaPi-IIa phosphate cotransporter
from the brush border membrane of proximal tubules in rats
and mice [2, 3, 7, 12, 31, 51]. NaPi-IIa is then routed via
clathrin-coated pits and early endosomes to lysosomes and
subsequently undergoes degradation [3, 22, 35, 41].
Interestingly, the time course of renal phosphaturia and
brush border membrane expression of NaPi-IIa do not
strictly correlate following an acute PTH bolus [15].
Furthermore, Tenenhouse and colleagues observed that in
mice lacking the NaPi-IIa transporter (Slc34a1−/−), PTH
injections in vivo (2 h) did not reduce phosphate uptake
rates in isolated brush border membrane vesicles (BBMV)
and had no effect on phosphaturia [51]. Indeed, Segawa et
al. reported PTH-reduced brush border membrane NaPi-IIc
expression only 8 h after injection [38]. Taken together,
these observations strongly suggest that acute PTH may
differentially affect expression and/or function of brush
border membrane phosphate transporters.
Therefore, we examined the acute effects of PTH on the
expression and function of all three brush border membrane
sodium-dependent phosphate cotransporters in rat kidney.
Our data demonstrate that PTH differentially regulates
NaPi-IIa, NaPi-IIc, and Pit-2 allowing for the fine-tuning
of renal phosphate reabsorption.
Materials and methods
Animals
The experiments were performed with male Wistar rats
(120–150 g, Charles River, Germany). The rats were kept
on a low-phosphate diet (0.1% Pi content; Kliba AG,
Switzerland) for 3 days to upregulate renal phosphate
reabsorption in the BBM of all proximal tubular segments
as described previously [3]. The protein abundance of all
three known phosphate transporters, NaPi-IIa, NaPi-IIc, and
Pit-2, is increased by low phosphate diets [27, 34, 36, 37].
Moreover, all rats received 4% CaCl2 in their drinking
water 24 h prior to experiments to suppress endogenous
PTH levels [3]. On the day of the experiment, all animals at
8 a.m. received either saline as control or PTH (PTH 1–34
fragment, 10 μg/100 g body weight (Sigma, St Louis, MO,
USA)) injections as a bolus into the tail vein. Some rats
were killed after 30 or 60 min to collect kidneys for the
preparation of brush border membrane vesicles. The
remaining rats were fixed by perfusion at each time point
(30, 60 min). Application of leupeptine (12 mg/ml
phosphate-buffered saline (PBS)) 15 min before injection
of PTH was also performed as described previously [3].
All animal studies were according to Swiss Animal
Welfare laws and approved by the local Cantonal Veterinary
Authority of Zurich.
Fixation
After treatment, all animals were fixed by vascular
perfusion via the abdominal aorta, at a pressure of 0.4 bar,
as described previously [3]. Rats were anesthetized with
thiopental (Pentothal, 100 mg/kg body weight) injected
intraperitoneally, their abdominal cavity was opened, and
the aorta and vena cava were exposed. The fixative
consisted of 3% paraformaldehyde, 0.1% glutaraldehyde,
and 0.05% picric acid in 0.6 M cacodylate buffer (pH 7.4;
containing 3 mM MgCl2 and adjusted to 300 mosmol/l with
sucrose) and 4% hydroxyethyl starch in saline (HAES
steril; Fresenius, Stans, Switzerland). After 5 min, the
fixative was washed out by perfusion with hydrostatic
pressure of 70 cm for 5 min with cacodylate buffer.
Kidneys were removed.
Immunohistochemistry
Slices of fixed kidneys were frozen in liquid propane and
cooled with liquid nitrogen. Serial sections, 4-μm thick,
were cut at −22°C on a cryomicrotome, mounted on
chromalum/gelatine-coated glass slides, thawed, and kept
in cold PBS until use. Before immunofluorescence staining,
sections were pretreated with blocking solution (Normal
Goat Serum 5% in PBS with 0.1% bovine serum albumin)
for 60 min. After blocking, serial sections were incubated
overnight at 4°C either with a rabbit anti-rat antiserum
against the NaPi-IIa protein [13] diluted 1:1,000 or with an
immunopurified rabbit anti-mouse NaPi-IIc [33] diluted
1:1,500 or a rabbit anti-rat Pit-2 [43] diluted 1:250. We also
tested two commercially available anti-Pit-2 antibodies
(Alpha Diagnostics, San Antonio, TX, USA, and Santa
Cruz Biotechnologies, Santa Cruz, CA, USA) but could not
obtain specific signals by immunohistochemistry of kidneys
or immunoblotting of brush border membranes from rats
with phosphate depletion. All primary antibodies were
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diluted in PBS with 0.1% bovine serum albumin. Sections
were then rinsed three times with PBS and covered for 1 h
at 4°C with the secondary antibodies: Alexa Fluor 555
goat–anti-rabbit IgG (1:500, Invitrogen), FITC–phalloidin
(Molecular probes, Eugene, OR, USA, 1:50), and 4,6-
diamidino-2-phenylindole (DAPI; Sigma, St Louis, MO),
dilution 1:1,000). Finally, the sections were rinsed three
times with PBS, coverslipped using DAKO-Glycergel
(Dakopatts) containing 2.5% 1,4-diazabicyclo[2.2.2]octane
(Sigma) as a fading retardant.
Immunohistochemistry images were acquired with a
Leica DFC490 charged-coupled device camera attached to
a Leica DM 6000 fluorescence microscope (Leica, Wetzlar,
Germany) using equivalent camera parameters for kidneys
sections stained with the same primary antibody. Pictures
were processed using Adobe Photoshop (overlays).
Brush border membrane vesicle preparation and phosphate
uptake experiments
BBMV were prepared from rat kidney cortex and outer
medulla using the Mg2+ precipitation technique as described
previously [8, 9]. The phosphate transport rate into BBMV
was measured in freshly prepared BBMV at 25°C in the
presence of inward gradients of 100 mM NaCl or 100 mM
KCl and 0.1 mM K-phosphate. The substrate Pi was made
with 0.125 mM K2HPO4 and
32P (1 μCi/ml) to give a final
concentration 0.1 mM close to the expected apparent KmPi
for Na+-dependent transport in renal BBMV. The stop
solution contained 100 mM Mannitol, 5 mM Tris–HCl pH
7.4, 150 mM NaCl, 5 mM Pi. Na+-dependence was
established by incubating BBMV in solutions in which
KCl replaced NaCl equimolarly. Phosphate uptake was
determined after 60 s, representing initial linear conditions,
and after 120 min, to determine the equilibrium values. In
order to distinguish between Na+-dependent Pi uptake
mediated by SLC34 family members (e.g., NaPi-IIa and
NaPi-IIc) and other Na+-dependent phosphate transporters
such as SLC20 family members (e.g., Pit-1 and Pit-2), we
used Trisodium phosphonoformic acid (PFA, final concen-
trations 0.1–6 mM) added to the same solution with
107 mM NaCl. PFA has previously been shown to have a
higher selectivity for SLC34 than SLC20 phosphate trans-
porters at these concentrations [11, 36, 43, 44]. Total
protein concentration was measured using the Bio-Rad
Protein Assay kit, Bio-Rad, Hercules, CA, USA. BBMV
were stored at −80°C until further use.
Immunoblotting
Ten micrograms of renal brush border membrane proteins
were solubilized in loading buffer containing DTT and
separated on 8% polyacrylamide gels. For immunoblotting,
the proteins were transferred electrophoretically to poly-
vinylidene fluoride membranes (Immobilon-P, Millipore
Corp., Bedford, MA, USA). After blocking with 5% milk
powder in Tris-buffered saline/0.1% Tween-20 for 60 min,
the blots were incubated with the primary antibodies: rabbit
polyclonal anti-NaPi-IIa (1:6,000) [13], rabbit polyclonal
anti-NaPi-IIc (1:10,000) [33], rabbit polyclonal anti-Pit-2
(1:3,000) [43], and mouse monoclonal anti-β-actin anti-
body (42 kD; Sigma, St. Louis, MO; 1:5,000) either for 2 h
at room temperature or overnight at 4°C. Membranes were
then incubated for 1 h at room temperature with secondary
goat anti-rabbit or donkey anti-mouse antibodies 1:5,000
linked to alkaline phosphatase (Promega, Madison, WI,
USA) or HRP (Amersham Life Science, Little Chalfont
Buckinghamshire, UK). The protein signal was detected
with the appropriate substrates (Millipore Corp, Bedford,
MA, USA) using the DIANA III-chemiluminescence
detection system (Raytest, Straubenhardt, Germany). All
images were analyzed using the software Advanced Image
Data Analyser AIDA (Raytest, Straubenhardt, Germany) to
calculate the protein of interest/β-actin ratio.
Statistical analysis
All data are summarized as mean ± SE and were analyzed
using the unpaired Student’s t test with only p values ≤0.05
considered as statistically significant.
Results
Parathyroid hormone decreases at least two types of sodium-
dependent phosphate transport activities
BBMV were prepared from kidneys of rats adapted to low
phosphate diet for 3 days and injected either with saline
(0.9% NaCl) or PTH. Sodium-dependent phosphate uptake
was measured in the absence and presence of 6 mM PFA.
PFA has been known to inhibit BBMV phosphate uptake
for almost three decades [39, 40] and has more recently
been shown to affect only type II (i.e., NaPi-IIa and NaPi-IIc)
but not type III (i.e., Pit-2) mediated phosphate transport at
this concentration[43, 44]. Thirty minutes after PTH injec-
tions, sodium-dependent phosphate uptake was reduced
from 3,570 ± 294 pmol/mg protein to 2,987 ± 316 pmol/mg
protein (p = 0.1, non-significant). After 60 min, the uptake
was reduced from 4,244 ± 241 pmol/mg protein to
3,095 ± 403 pmol/mg protein (p = 0.015, significant;
Fig. 1a). In the presence of PFA, however, the total sodium-
dependent phosphate uptake was reduced by about 70%
indicating that type II phosphate transporters are responsi-
ble for about 70% of the total sodium-dependent phosphate
transport activity in chronically low phosphate fed rats.
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PFA-resistant phosphate uptake was further decreased from
1,091 ± 50 pmol/mg protein to 767 ± 46 pmol/mg protein
after 30 min PTH (p = 0.0007, significant) and from
1,264 ± 116 pmol/mg protein to 808 ± 77 pmol/mg protein
after 60 min PTH (p = 0.004, significant) (Fig. 1b). We
further characterized the inhibition of sodium-dependent
phosphate uptake into brush border membrane vesicles
from rats injected either with saline (control) or PTH
(30 min) using increasing concentrations of PFA in the
range of 0.1 mM to 6 mM (Fig. 1c). Increasing concen-
trations decreased Na+-dependent phosphate uptake pro-
gressively. We did not use concentrations higher than 6 mM
since preliminary experiments suggested unspecific effects
on other transport systems such as for glucose (data not
shown). We also estimated the apparent half-maximal
concentration (EC50) of PFA needed to inhibit Na
+-
dependent phosphate uptake and obtained values of
approximately 3 mM both in saline and PTH-treated brush
border membranes (Fig. 1d). Thus, PTH decreases both the
PFA-sensitive and the PFA-resistant sodium-dependent
phosphate transport activities suggesting that type II and
type III transporter(s) are downregulated.
PTH induces internalization and lysosomal degradation
of the type II NaPi-IIa cotransporters
Acute application of PTH leads to the rapid internalization of
the NaPi-IIa cotransporter from the brush border membrane
and its subsequent routing to the lysosome and degradation
[3, 22, 35, 41]. We used immunohistochemistry on
consecutive sections of rat kidneys to examine the localiza-
tion of NaPi-IIa, NaPi-IIc, and Pit-2 after application of
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Fig. 1 Parathyroid hormone (PTH) decreases brush border membrane
sodium-dependent phosphate uptake in the absence and presence of
phosphonoformic acid (PFA). Rats were injected either with saline
(control) or PTH, and kidneys were harvested 30 or 60 min after
injections. Brush border membrane vesicles were prepared, and
sodium-dependent phosphate fluxes were measured in the absence
(a) or presence of 6 mM PFA (b), an inhibitor of type II but not
type III phosphate cotransporters (n = 5 each group and time point).
PTH decreased the total and PFA-resistant phosphate uptake
indicating that type II and type III transporters are regulated by
PTH. c Sodium-dependent phosphate uptake rates in the presence of
increasing concentrations of PFA (0.1–6 mM) into brush border
membrane vesicles prepared from rats injected with saline (control)
or PTH (30 min). d Phosphate transport rates were normalized
against rates in the absence of PFA and the apparent half-maximal
PFA concentration calculated (EC50) needed to inhibit phosphate
uptake (n = 4 each group and time point). *p < 0.05, ** p < 0.01,
*** p < 0.001
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Pit2
Control
30 min.
60 min.
60 min.
leupeptin
NaPilla NaPillcFig. 2 Effect of acute PTH on
NaPi-IIa, NaPi-IIc, and Pit-2
immunostaining. Rats were
injected with NaCl (control), or
PTH (30 and 60 min). Some rats
received also leupeptin prior to
PTH to prevent lysosomal
degradation (n = 5 animals per
group). Cryostat serial sections
were stained for Pit-2, NaPi-IIa,
and NaPi-IIc. In control kidneys,
NaPi-IIa-related staining was
seen along the entire length of
the proximal tubule (S1–S3
segments) and in both super-
ficial and juxtamedullary
nephrons. In contrast, NaPi-IIc
and Pit-2 staining was mostly
observed in early convoluted
proximal tubules (S1 segments)
with similar intensities in super-
ficial and juxtamedullary
nephrons. After PTH injection,
NaPi-IIa labeling intensity was
reduced in kidneys 30 and
60 min after PTH application
whereas Pit-2- and NaPi-IIc-
related labeling intensity
remained unchanged. Inhibition
of lysosomal activity with
leupeptin increased the intensity
of NaPi-IIa staining in PTH
injected rats; the staining for
NaPi-IIc and Pit-2 appeared
unaffected. Bar size ∼40 μm
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PTH or saline, respectively. In saline-treated animals, no
differences in the segmental and subcellular localization of
NaPi-IIa, NaPi-IIc, and Pit-2 between control and after 30 or
60 min PTH were observed (Fig. 2). In control kidneys from
animals on a low phosphate diet, NaPi-IIa-related staining
was seen in superficial and juxtamedullary nephrons along
the entire length of the proximal tubule (S1–S3 segments).
In contrast, NaPi-IIc and Pit-2 staining was mostly observed
in early convoluted proximal tubules (S1 segments) with
similar intensities in superficial and juxtamedullary nephrons.
After PTH injection, NaPi-IIa labeling intensity was
reduced in kidneys at both time points (30 and 60 min),
whereas Pit-2- and NaPi-IIc-related labeling intensity
appeared unchanged (Fig. 2). Segmental differences in the
response to PTH were observed. The strongest effect of
PTH was seen in the early proximal tubules of superficial
nephrons (S1 segments) where PTH induced a strong
decrease of NaPi-IIa-related staining in the brush border
membrane and the intracellular appearance of staining
(Fig. 3). We have previously shown that these intracellular
structures include clathrin-coated pits, early endosomes,
and lysosomes [3]. In the S2 segment of superficial
nephrons, NaPi-IIa internalization was also observed;
however, strong residual NaPi-IIa staining in the brush
border membrane was seen (Fig. 4). In juxtamedullary
nephrons, almost no difference in NaPi-IIa staining between
control, saline-, and PTH-treated kidneys could be observed
(data not shown). In contrast to NaPi-IIa staining, no
changes in NaPi-IIc- or Pit-2-related staining (both apparent
intensity and subcellular localization) could be detected on
the level of light microscopy at any time point in superficial
and juxtamedullary proximal tubules (Figs. 3 and 4).
In order to examine if NaPi-IIc or Pit-2 may be rapidly
routed to lysosomes and degraded, we pretreated rats with
leupteptin
Fig. 3 Acute PTH induces
internalization and lysosomal
degradation of NaPi-IIa but not
NaPi-IIc and Pit-2 in S1
proximal tubules. S1 segments
of superficial nephrons stained
with antibodies against Pit-2,
NaPi-IIa, or NaPi-IIc (green
label) and with rhodamine–
phalloidin against β-actin fila-
ments (red) to mark brush
border membranes. Serial sec-
tions are shown. Under control
conditions, Pit-2, NaPi-IIa,
and NaPi-IIc stainings are
predominantly localized in the
BBM. Thirty minutes after PTH
injection, the intensity of the
NaPi-IIa staining in the BBM is
reduced whereas intracellular
NaPi-IIa staining (green) is
strongly increased. Pit-2 and
NaPi-IIc staining is only
detectable in the BBM at all
time points, and its intensity
remained unaltered. Blockade of
lysosomal degradation with
leupeptin caused accumulation
of NaPi-IIa staining in
lysosomes whereas no NaPi-
IIc- and Pit-2-related staining
could be observed. N = 5
animals per group.
Bar size ∼10 μm
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leupeptin to inhibit lysosomal degradation of proteins.
Leupeptin treatment enhanced the signal for NaPi-IIa after
30 and 60 min in lysosomes whereas no staining for NaPi-
IIc and Pit-2 could be found (Figs. 3 and 4).
PTH decreases brush border membrane expression of NaPi-IIa
and Pit2 but not NaPi-IIc
In a next step, we prepared brush border membranes for
immunoblotting to examine the relative abundance of NaPi-
IIa, NaPi-IIc, and Pit-2 after 30 and 60 min PTH
application. Thirty minutes after PTH application, the
relative abundance of NaPi-IIa and Pit-2 was significantly
reduced in the brush border membrane, whereas NaPi-IIc
abundance remained unchanged (Fig. 5a, b). Similarly,
60 min after PTH application, NaPi-IIa abundance was
significantly decreased. Pit-2 abundance was lower than in
the respective control group but did not reach anymore
statistical significance (p = 0.07; Fig. 5a, b). Thus, PTH
treatment acutely decreases expression of NaPi-IIa and Pit-
2 in the brush border membrane.
Discussion
The acute effects of PTH on the activity and localization of
the renal sodium-phosphate cotransporter NaPi-IIa has been
studied in great detail using mouse and rat models, isolated
perfused proximal tubules as well as the OK cell model
[3, 20, 21, 26, 29, 42, 48]. Taken together, these studies
demonstrated that PTH binds to receptors localized at the
basolateral membrane and in the brush border membrane
[12, 30, 42]. Both cAMP- and PKC-dependent pathways
may at least in part converge in ERK1/2 and induce the
Pit2
Control
30 min.
60 min.
60 min.
leupeptin
NaPilla NaPillcFig. 4 Weak effect of PTH in
S2 segments on NaPi-IIa
internalization. S2 segments of
superficial nephrons were
stained with antibodies against
Pit-2, NaPi-IIa, or NaPi-IIc
(shown in green) and with
rhodamine–phalloidin against
β-actin filaments (red) to mark
brush border membranes. Serial
sections are shown. In kidneys
from control animals, NaPi-IIa
mostly resided in the brush
border membrane. Pit-2 showed
a weaker signal than in S1
segments whereas NaPi-IIc was
barely detectable in superficial
S2 proximal tubules. Thirty
minutes after PTH injection, the
intensity of the intracellular
NaPi-IIa staining (green) was
increased whereas Pit-2 was
only detectable at the BBM. A
pool of NaPi-IIa was still
present in the BBM. Pretreat-
ment with leupeptin caused a
more intensive intracellular
lysosomal staining for NaPi-IIa;
no intracellular or lysosomal
signal could be detected for
NaPi-IIc and Pit-2. N=5 animals
per group. Bar size ∼10 μm
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internalization of NaPi-IIa [4]. NaPi-IIa localized in the
brush border membrane forms part of a multiprotein
complex and interacts via its PDZ-binding motif with the
scaffolding protein NHERF1 [16, 18, 25, 49]. PTH
enhances NHERF1 phosphorylation leading to dissociation
of the NaPi-IIa–NHERF1 complex and enabling NaPi-IIa
routing to clathrin-coated pits, early endosomes, and
ultimately to lysosomes [14, 48]. The mechanisms and
signals governing the internalization or regulation of NaPi-
IIc and the recently described Pit-2 are not known to date.
Here, we examined the acute effects of PTH on all three
known isoforms of renal brush border membrane sodium-
phosphate cotransporters using three complimentary
approaches. We demonstrate that acute application of PTH
causes within 30 min a reduction in total sodium-dependent
phosphate transport in isolated brush border membrane
vesicles that became significant after 60 min. Importantly,
the use of PFA allowed distinguishing at least two types of
phosphate transport activities. Dousa and colleagues had
demonstrated more than 20 years ago that brush border
membrane phosphate transport could be partly blocked by
PFA and related substances [40]. We and others have
shown that PFA acts on type II phosphate transporters
(NaPi-IIa, NaPi-IIb, and NaPi-IIc) expressed heterologously
in Xenopus oocytes and that concentrations in the range of
3–6 mM block about 80–90% of activity [11, 44].
Importantly, type III phosphate transporters (Pit-1 and
Pit-2) appear to be much less sensitive to this class of
molecules and show only mild inhibition at concentrations
higher than 10 mM [36, 43]. The fact that the PFA-
resistant sodium-dependent uptake was also reduced by
PTH strongly suggests that PTH acts also on the BBM
abundance and/or activity of non-type II phosphate trans-
porters. To further evaluate the inhibition of phosphate
transport, we estimated the apparent half-maximal concen-
tration of PFA required to inhibit phosphate transport in
brush border membrane vesicles obtained from control and
PTH injected rats. Our data demonstrate that PTH affected
only the maximal transport rate of phosphate and the PFA
inhibitable fraction but did not alter the apparent EC50 for
PFA which remained in the range of about 3 mM. These
data are in perfect agreement with previous data from rat
a
b
Fig. 5 Parathyroid hormone (PTH) decreases the abundance of NaPi-
IIa and Pit-2 in the brush border membrane. Brush border membranes
were prepared from kidneys of PTH and saline (control) injected rats
(n = 5 animals per condition) and 10 μg loaded per lane for
immunoblotting. a Membranes were tested for NaPi-IIa, NaPi-IIc,
and Pit-2 and stripped to reprobe for β-actin to control for loading. b
Densitometric analysis of membranes was performed, and the bands
for the transporters of interest were normalized against β-actin and the
respective control groups. PTH decreased NaPi-IIa abundance
significantly 30 and 60 min after PTH injections. Pit-2 abundance
was reduced significantly 30 min after PTH, whereas NaPi-IIc
abundance was unaltered at both time points. *p < 0.05, **p < 0.01
b
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brush border membrane vesicles where binding of radio-
labelled PFA and inhibition of phosphate transport were
studied and an apparent Km for binding of ∼3.6 mM was
found [39]. Also in agreement with the work of Dousa and
colleagues, we find that about 25–30% of overall sodium-
dependent phosphate uptake at the highest concentration of
PFA (6 mM) is resistant to the inhibitory effect. Higher
concentrations were not used since PFA starts to exert
unspecific effects at concentrations of 10 mM and higher
(unpublished results). Thus, these data suggest that PTH
acts on at least two different populations of phosphate
transporters, PFA-sensitive and PFA-insensitive ones.
Consistent with the PFA data, we observed that PTH
reduced NaPi-IIa and Pit-2 abundance in isolated brush
border membranes as detected by immunoblotting. NaPi-IIc
expression was not altered by PTH in agreement with an
earlier report showing that NaPi-IIc abundance decreased
only approximately 8 h after PTH injection [38]. Immuno-
histochemistry confirmed that PTH reduced brush border-
localized NaPi-IIa-related staining as described previously
[3, 29]. Intracellular NaPi-IIa staining increased after PTH
injection, and blockade of lysosomal degradation with
leupeptin showed accumulation of intracellular NaPi-IIa in
structures identified previously as lysosomes [3, 29]. In
contrast to the findings for NaPi-IIa and the reduced
abundance of Pit-2 as shown by immunoblotting, no
changes in NaPi-IIc- and Pit-2-related stainings could be
detected at the level of light microscopy. This discrepancy
for Pit-2 might be due to our antibodies that might detect
Pit-2 in immunohistochemistry only in a specific confor-
mation. Alternatively, the binding site for the antibody
might be blocked by an interacting protein that associates
with Pit-2 upon PTH application. We also tested two
commercially available antibodies against Pit-2 but failed to
detect specific signals preventing a further investigation of
this question. Clearly, the fate of Pit-2 following PTH
application will require further studies.
The distinct transport properties and differential regulation
by hormones and other factors with different time courses
allow for a better and finer adaptation of renal phosphate
reabsorption under various conditions. Differential regulation
of NaPi-IIa, NaPi-IIc, and Pit-2 occurs not only in response to
PTH. During dietary potassium restriction and hypokalemia,
increased expression of NaPi-IIa has been observed despite
phosphaturia [50]. Phosphaturia may be explained by the
downregulation of NaPi-IIc and Pit-2, providing another
example for differential regulation of BBM phosphate
transporters [10]. However, the relative contribution of these
transporters to overall renal phosphate handling and the
integration of several signals on the level of the proximal
under these circumstances remain an open question. PTH
application elicits a rapid phosphaturic response both in
humans and rodents [15, 19]. In contrast to rodents, several
lines of evidence suggest that NaPi-IIa may not be the major
type II phosphate transporters in human kidney. Missense
and even truncating mutations in NaPi-IIa (SLC34A1) do not
cause phosphaturia in humans [23, 46], whereas mutations in
NaPi-IIc (SLC34A3) are associated with massive phos-
phaturia, hypophosphatemia, rickets, and hypercalcuria
suggesting that NaPi-IIc is an important contributor to renal
phosphate reabsorption [5, 28]. The expression of Pit-2 and
the relevance of a PFA-sensitive phosphate transport activity
in the brush border membrane have not been studied in
human kidney and remain unknown to date. If NaPi-IIa does
not play a major role in human kidney and if NaPi-IIc does
internalize or inactivate only with a delayed time course (as
indicated by studies in rodents [38]), then other phosphate
transporters must mediate the acute phosphaturic effect of
PTH in humans [19]. Whether Pit-2 could be a candidate for
this transport activity remains to be investigated in humans
and human cell lines. Differential regulation of the three
known phosphate transporters in the brush border membrane
would allow to fine-tune phosphate excretion not only to
PTH status but also to other regulating factors such as
dietary phosphate intake, acid–base status, vitamin D3, and
others. In fact, renal phosphate excretion is almost refractory
to PTH during growth or if systemic phosphate depletion
exists [17, 47]. How this fine-tuning is achieved remains to
be further examined.
In summary, we demonstrate that acute application of
PTH affects the brush border membrane expression of NaPi-
IIa and Pit-2 in rat kidney. PTH also reduces PFA-sensitive
and PFA-insensitive phosphate transport activities. There-
fore, our data suggest that renal brush border membrane
phosphate transporters are differentially regulated by acute
application of PTH.
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